# Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors

> **NCT00002489** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center**

## Conditions studied

- Extragonadal Germ Cell Tumor
- Ovarian Cancer

## Interventions

- **BIOLOGICAL:** dactinomycin
- **BIOLOGICAL:** filgrastim
- **DRUG:** carboplatin
- **DRUG:** cyclophosphamide
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** etoposide
- **DRUG:** leucovorin calcium
- **DRUG:** methotrexate
- **DRUG:** vincristine sulfate
- **PROCEDURE:** conventional surgery

## Key facts

- **NCT ID:** NCT00002489
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1991-10
- **Primary completion:** 2002-06
- **Final completion:** 2002-06
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002489

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002489, "Combination Chemotherapy in Treating Children With Non-testicular Malignant Germ Cell Tumors". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00002489. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*